Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2014

Mar 11, 2014

32566_dirs_2014-03-11_03915796-a9ac-4e43-8ae3-f3379f79e23b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-03-07

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-03-07 Common Stock M 20000.0 $7.6 Acquired 24000 Direct
2014-03-07 Common Stock S 20000.0 $37.8598 Disposed 4000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-03-07 Non-Qualified Stock Option (right to buy) $7.6 M 20000.0 Disposed 2016-01-06 Common Stock (20000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 300 Indirect

Footnotes

F1: One third vests annually beginning on the 1st anniversary of the option date.